清晰可见的危险:确定谁有Cefepime诱导的神经毒性及其相关发病率和死亡率的最高风险
Brin E Freund1, Khalil S Husari2,3, Peter W Kaplan3
1Department of Neurology, Mayo Clinic, Jacksonville, FL, USA. freund.brin@mayo.edu.
Acta neurologica Belgica
|April 8, 2024
概括
塞费皮姆诱导的神经毒性 (CIN) 存在风险,特别是在危急病患者中. 通过风险因素分析和EEG的早期识别可以改善这种严重疾病的诊断和管理.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 关键护理医学 关键护理医学
- 神经科学是一个神经科学.
背景情况:
- 塞菲皮姆是第四代塞法洛斯波林,是一种常见的败血症治疗方法.
- 塞费皮姆诱导的神经毒性 (CIN) 是一种严重的不良影响,可能导致和死亡.
- 现有的研究,比如ACORN试验,可能不能完全代表CIN的高风险人群 (重症患者,老年人).
研究的目的:
- 要突出与塞费皮姆诱导的神经毒性 (CIN) 相关的风险因素.
- 讨论电脑电图 (EEG) 在诊断CIN时的有用性.
- 提出CIN的诊断和管理策略,特别是在重症监护机构.
主要方法:
- 迷你审查方法综合了CIN.现有的文献.
- 对导致塞费皮姆诱导的神经毒性的风险因素的分析.
- 讨论诊断工具,包括实验室测试和EEG.
主要成果:
- 已确定患有CIN.IN风险较高的患者群体.
- 强调了CIN在患有脑病变的重症患者中所面临的诊断挑战.
- 突出了对CIN缺乏明确的诊断标准.
结论:
- 早期识别CIN对于及时治疗和区分从脑病变的其他原因至关重要.
- 确定风险因素和使用EEG可以帮助临床诊断CIN.
- 对于患有塞费皮姆诱导神经毒性风险的患者,需要采用结构化的诊断和管理方法.
更多相关视频
08:23Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line
Published on: August 9, 2014
11.4K
08:27Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
Published on: October 29, 2014
11.1K
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
288
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
288
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
160
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
160
